Clinical Outcomes of Haploidentical Donor Compared with Unrelated and HLA-Matched Related Donor Hematopoietic Stem Cell Transplantation for Hematologic Malignancies

被引:0
|
作者
Luo, Yi [1 ]
Tan, Yamin [1 ]
Lai, Xiaoyu [1 ]
Zheng, Weiyan [1 ]
Shi, Jimin [1 ]
Zheng, Gaofeng [1 ]
Huang, He [1 ]
机构
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou 310003, Zhejiang, Peoples R China
关键词
D O I
10.1182/blood.V120.21.4159.4159
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4159
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Comparison of Quality of Life and Outcomes between Haploidentical and Matched Related/Unrelated Donor Allogeneic Hematopoietic Cell Transplantation
    Hong, Sanghee
    Rybicki, Lisa
    Mclellan, Linda
    Dabney, Jane
    Gerds, Aaron T.
    Rotz, Seth J.
    Kalaycio, Matt
    Hanna, Rabi
    Hamilton, Betty K.
    Majhail, Navneet S.
    Sobecks, Ronald M.
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (04): : 217.e1 - 217.e6
  • [22] Outcomes after Matched Unrelated Donor and Haploidentical Related Donor Allogeneic Transplantation for Hematological Malignancies: Single Center Experience
    Gupta, Ridhi
    Khanal, Rashmi
    Burbridge, Mark Thomas
    Mayer, Elizabeth Garrett
    Baldino, Ellen
    Butcher, Colleen
    Capdevil, Kylie
    Edwards, Kathy Hogan
    Gentles, Carolyn Ann
    Hoffman, Randi
    Littleton, Amanda
    Martin, Kristy
    Kramer, Cindy
    Schneider, Molly
    Sedov, Valeriy
    Varela, Juan Carlos
    Williams, Elizabeth J.
    Stuart, Robert
    Chhabra, Saurabh
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S370 - S371
  • [23] The Effect of Donor Type on Survival in Children Receiving Hematopoietic Stem Cell Transplant (HCT) for Hematologic Malignancies (HM) in Florida (2015-2020): Comparison of Matched Sibling Donor (MSD), 8/8 HLA-Matched Unrelated Donor (MUD), and Haploidentical Donor (HD) Transplants
    Alperstein, Warren
    Hardit, Viney
    Crawford, David
    Ziga, Edward
    Chellapandian, Deepak
    Silva, Jorge Galvez
    Oshrine, Benjamin
    Joyce, Michael
    Castillo, Paul
    Fort, John
    Ligon, John
    Wang, Shu
    Cline, Jessica
    Yang, Fan
    Horn, Biljana
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [24] Autoimmune Hematological Diseases Following Haploidentical Donor Hematopoietic Stem Cell Transplant Compared with Matched Sibling and Unrelated Donor
    Lv, Weiran
    Liu, Qifa
    Fan, Zhiping
    Huang, Fen
    Xu, Na
    Xuan, Li
    Yu, Guopan
    Jiang, Qianli
    Zhou, Hongsheng
    Lin, Ren
    Sun, Jing
    Zhang, Xin
    BLOOD, 2016, 128 (22)
  • [25] Partially Matched Related Donor Transplantation Can Achieve Outcomes Comparable to Unrelated Donor Transplantation for Patients with Hematologic Malignancies.
    Huang, Xiao Jun
    Xu, Lan-Ping
    Liu, Kai Yan
    Liu, Dai-Hong
    Wang, Yu
    Chen, Huan
    Chen, Yu-Hong
    Han, Wei
    Wang, Jing-Zhi
    Chen, Yao
    Zhang, Xiao-Hui
    Shi, Hongxia
    Wang, Feng-Rong
    Tang, Fei-Fei
    BLOOD, 2009, 114 (22) : 492 - 492
  • [26] Autoimmune hematological diseases following haploidentical donor hematopoietic stem cell Transplant compared with matched sibling and unrelated donor
    Lv, Weiran
    Fan, Zhiping
    Huang, Fen
    Xu, Na
    Xuan, Li
    Yu, Guopan
    Jiang, Qianli
    Zhou, Hongsheng
    Lin, Ren
    Zhang, Xin
    Sun, Jing
    Liu, Qifa
    ONCOTARGET, 2017, 8 (16) : 26505 - 26514
  • [27] T Cell-Replete HLA Haploidentical Donor Transplantation with Post-Transplant Cyclophosphamide Is an Effective Salvage for Patients Relapsing after an HLA-Matched Related or Matched Unrelated Donor Transplantation
    Gorgeis, Jessica
    Zhang, Xu
    Connor, Katelin
    Brown, Stacey
    Solomon, Scott R.
    Morris, Lawrence E.
    Holland, H. Kent
    Bashey, Asad
    Solh, Melhem
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (10) : 1861 - 1866
  • [28] HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide versus HLA-Matched Unrelated Donor Transplantation for Myelodysplastic Syndrome
    Nakaya, Yosuke
    Koh, Hideo
    Konuma, Takaaki
    Shimomura, Yoshimitsu
    Ishiyama, Ken
    Itonaga, Hidehiro
    Hino, Masayuki
    Doki, Noriko
    Nishida, Tetsuya
    Ohigashi, Hiroyuki
    Matsuoka, Ken-ichi
    Kanda, Yoshinobu
    Maruyama, Yumiko
    Sawa, Masashi
    Eto, Tetsuya
    Hiramoto, Nobuhiro
    Fukuda, Takahiro
    Atsuta, Yoshiko
    Nakamae, Hirohisa
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (03): : 316.e1 - 316.e12
  • [29] Risk of Cytomegalovirus Infection with Post-Transplantation Cyclophosphamide in Haploidentical and HLA-Matched Unrelated Donor Transplantation
    Jamy, Omer
    Hebert, Courtney
    Dunn-Valadez, Sydney
    Magnusson, Tylan
    Watts, Nicole
    McGwin, Gerald
    Saad, Ayman
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (04): : 213.e1 - 213.e6
  • [30] Outcomes of Hematologic Malignancies after Unrelated Donor Hematopoietic Cell Transplantation According to Place of Residence
    Loberiza, Fausto R., Jr.
    Lee, Stephanie J.
    Klein, John P.
    Hassebroek, Anna
    Dehn, Jason G.
    Frangoul, Haydar A.
    Hahn, Theresa
    Hale, Gregory
    Lazarus, Hillard M.
    LeMaistre, Charles F.
    Maziarz, Richard T.
    Rizzo, J. Douglas
    Majhail, Navneet S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (03) : 368 - 375